The American laboratory Pfizer warned today of a delay “starting next week” in the delivery of its vaccines against coronavirus across Europe, to enable the company to prepare to increase its production capacity, Norwegian health officials said.
“The temporary reduction will affect all European countries,” the Norwegian Institute of Public Health said in a statement. “It is not yet clear how long it will take exactly for Pfizer to resume its maximum production capacity, which will rise from 1.3 billion to 2 billion doses”, he added.
The Norwegian institute did not provide details on the magnitude of the reduction in supply, but provided data for the country, which will receive 36,075 doses of the expected 43,875 next week, ie, 17.8% less.
To compensate for this reduction, Norway will use its vaccine stocks it created after receiving the first doses.
The country is not a member of the European Union, but it is closely linked to the bloc in multiple aspects, for example in the supply of vaccines against covid-19, which was administered directly by Brussels.